The relationship between DNA and prenatal parentage testing.

親子鑑定 NIPPT DNA鑑定 科学的根拠 原則

Summary of this article

Explains the relationship between DNA and prenatal parent-child identification. Details how genetic information can be used to confirm parent-child relationships during pregnancy, as well as its accuracy and reliability.

DNA and prenatal paternity testing are important techniques used to confirm parent-child relationships on a genetic level. The relationship is explained below.

1. The role of DNA

DNA (deoxyribonucleic acid) is the molecule that holds the genetic information and determines the genetic characteristics of each individual. As genetic information is passed on from parents to their children, there are many common parts in the DNA of parents and children. By analyzing these common parts, the parent-child relationship can be established.

2. Methods of prenatal paternity testing

In a prenatal paternity test, the following steps are usually taken to establish the parent-child relationship

  • Collecting samples from the mother: during pregnancy, fetal DNA is present in the mother’s blood. A sample of the mother’s blood is used to collect this DNA.
  • Sample collection from potential fathers: a DNA sample from the potential father is also required. This is usually obtained from an oral swab (cells collected from the inside of the cheek) or a blood sample.
  • DNA analysis: the DNA of the fetus in the mother’s blood is compared with that of the potential father to determine how many genetic matches there are. This confirms whether the prospective father is the biological father of the fetus.

3. Accuracy and ethical considerations

Prenatal paternity appraisals are highly accurate, but should be conducted with caution from an ethical point of view. As such appraisals are deeply concerned with family issues and personal privacy, it is recommended that legal advice and counselling be sought when undertaking them.

Thus, DNA is the basis for scientific and reliable proof of parent-child relationships in prenatal paternity testing.

医師監修 監修日:2024年8月28日

岡 博史 (おか ひろし)

医師・医学博士 ヒロクリニック統括院長

YouTubeチャンネルなどを通じて、遺伝子やNIPT(新型出生前診断)についてわかりやすく発信しています。

略歴

  • 1996年 慶應義塾大学医学部 卒業
  • 2004年 慶應義塾大学 医学博士号 取得
  • 2005年 慶應義塾大学 皮膚科学教室 助手
  • 2008年 ヒロ皮フ形成クリニック 開業
  • 2009年 医療法人社団福美会 理事長
  • 2015年 医療法人社団福美会 理事

資格・所属

  • CAPラボディレクター
  • 日本皮膚科学会 皮膚科専門医
  • 日本医師会 産業医
  • 東京衛生検査所 指導監督医

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

医師監修 監修日:2024年8月28日

堤 修一 (つつみ しゅういち)

医師・医学博士 ヒロクリニック博多駅前院 院長

略歴

  • 1993年 東京大学医学部医学科 卒業
  • 2016〜2019年 東京大学先端科学技術研究センター 准教授

発信・関連リンク

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

Supervisor of the article


Dr. Hiroshi Oka

Director of CAP Laboratory

Graduated from Keio University, Faculty of Medicine

Doctor of Medicine

Medical Doctor